Published in J Clin Epidemiol on August 01, 2012
A Bayesian missing data framework for generalized multiple outcome mixed treatment comparisons. Res Synth Methods (2015) 0.93
Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ (2005) 4.40
Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health (2011) 3.88
Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. Value Health (2011) 2.88
Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value Health (2011) 2.05
The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia. AIDS (2008) 1.81
Probabilistic analysis and computationally expensive models: Necessary and required? Value Health (2006) 1.54
Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis. Ann Intern Med (2011) 1.51
Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med Res Methodol (2010) 1.21
Who does the numbers? The role of third-party technology assessment to inform health systems' decision-making about the funding of health technologies. Value Health (2008) 1.05
The efficacy and tolerability of perampanel and other recently approved anti-epileptic drugs for the treatment of refractory partial onset seizure: a systematic review and Bayesian network meta-analysis. Curr Med Res Opin (2013) 0.88
The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis. Exp Hematol Oncol (2013) 0.87
Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis. Eur J Health Econ (2009) 0.86
Cost-effectiveness of a supplementary class-based exercise program in the treatment of knee osteoarthritis. Int J Technol Assess Health Care (2006) 0.85
Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making (2005) 0.84
Management strategies for pancreatic pseudocysts. Cochrane Database Syst Rev (2016) 0.82
Glycopeptide vs. non-glycopeptide antibiotics for prophylaxis of surgical site infections: a systematic review. Surg Infect (Larchmt) (2010) 0.82
Cost-effectiveness of scheduled maintenance treatment with infliximab for pediatric Crohn's disease. Value Health (2009) 0.80
Prioritizing pharmacogenetic research: a value of information analysis of CYP2D6 testing to guide breast cancer treatment. Value Health (2011) 0.80
The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B: a systematic review and network meta-analysis. Syst Rev (2014) 0.80
Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma. Curr Med Res Opin (2007) 0.78
Bendamustine versus chlorambucil for the first-line treatment of chronic lymphocytic leukemia in England and Wales: a cost-utility analysis. Value Health (2012) 0.77
The use of individual patient-level data (IPD) to quantify the impact of pretreatment predictors of response to treatment in chronic hepatitis B patients. BMJ Open (2013) 0.75
An economic evaluation of preclinical testing strategies compared to the compulsory scrapie flock scheme in the control of classical scrapie. PLoS One (2012) 0.75
Extrapolation of survival data in cost-effectiveness analyses: improving the current state of play. Med Decis Making (2013) 0.75
Subgroup analyses in cost-effectiveness analyses to support health technology assessments. Pharm Stat (2014) 0.75
Cost-effectiveness of enhanced external counterpulsation (EECP) for the treatment of stable angina in the United Kingdom. Int J Technol Assess Health Care (2010) 0.75
Comparative effectiveness of antiviral treatment for hepatitis B: a systematic review and Bayesian network meta-analysis. Eur J Gastroenterol Hepatol (2015) 0.75